Dr. Mihaly Juhasz, founder of Accelsiors, brings a wealth of expertise and a proven track record to the pharmaceutical industry, making significant contributions to numerous drug development programs. Trained as an MD with board certification in clinical pharmacology and a strong background in pediatrics, his experience spans both CRO (Contract Research Organization) and Pharma sectors.
Over the past quarter-century, Dr. Juhasz has focused on neuroendocrine disorders, in both pediatric and adult populations. His involvement in clinical research has facilitated the successful registration of several drugs, a noteworthy accomplishment that has advanced the field of neuro-endocrinology and beyond.
Before establishing Accelsiors, Dr. Juhasz served as a Medical Director at Novartis Biologics (Biochemie). His strategic input played a significant role in the organization’s success. His reputation for innovation is also evident in the biosimilar development sphere, an area that now constitutes an essential part of Accelsiors’ operations, showcasing his commitment to the evolving landscape of biopharmaceuticals.
Before his stint at Novartis Biologics, he successfully navigated increasing responsibilities across various managerial roles at Quintiles, the world’s largest CRO at the time.
Throughout his career, Dr. Juhasz’s commitment in expanding scientific knowledge and improving patient care has been evident. His professional journey is a testament to his dedication in advancing innovation within the pharmaceutical industry.